データなし
コード銘柄名
現在値変化額変化率出来高売買代金始値前日終値高値安値時価総額浮動株時価株式総数浮動株5日変化率10日変化率20日変化率60日変化率120日変化率250日変化率年初来配当利回売買回転率直近PER前年PER振幅業種
お気に入り
Will Passage Bio (NASDAQ:PASG) Spend Its Cash Wisely?
Yun Zhong, PhD, Joins Wedbush Securities as Senior Vice President, Equity Research, Biotechnology
Passage Bio Assumed With an Outperform at Wedbush
Update: Wedbush Raises Price Target on Passage Bio to $4 From $3, Keeps Outperform Rating
The GenScript Biotech Global Forum Makes a Strong Debut in Europe, Highlighting Breakthroughs in Cell and Gene Therapy Development
Passage Bio Price Target Maintained With a $7.00/Share by Chardan Capital